A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery

NCT00208377 | Terminated Phase 4

• 1 other identifier: CT01/21
• Study Type: interventional
• Target: 228
• Locations: 3 countries
• Sites: 3

Brief Summary

The purpose of this study is to monitor the performance and determine the metal ion release of the DePuy ASR™ System in the treatment of patients with hip joint disease requiring hip resurfacing surgery. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments. A subset of patients will also have blood samples taken at regular intervals to allow the metal ion levels to be determined and undergo scans to allow the bone mineral density of the bone surrounding the implant to be monitored. DePuy decided to close this Study in 4Q 2009. The Study was terminated with effect from December 2010 to allow for the completion of the 5 year follow up assessments. Please note that subsequent to this decision DePuy voluntarily recalled the ASR products on 24 August 2010. Additional information regarding this voluntary recall and the follow-up of patients affected by the recall can be found at the following links http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON079157 and http://www.depuy.com/countries\_list.

Conditions

Rheumatoid Arthritis; Osteoarthritis; Post-traumatic Arthritis; Collagen Disorders; Avascular Necrosis; Nonunion of Femoral Fractures; Congenital Hip Dysplasia; Slipped Capital Femoral Epiphysis

Keywords

Hip; Conservative; Metal-on-Metal; Resurfacing

Outcome Measures

Primary Outcomes (1)

• Kaplan-Meier survivorship calculated annually

  Annually

Secondary Outcomes (7)

• UCLA Activity Score

  3 months, 6 months and then annually

• WOMAC Score

  3 months, 6 months and then annually

• Activity Assessment

  3 months, 6 months and then annually

• Harris Hip Score

  3mths, 1yr, 2 yrs, 5yrs, 10yrs and 15yrs post-surgery

• Radiographic analysis

  pre-discharge, 3mths, 1yr, 2 yrs, 5yrs, 10yrs and 15yrs post-surgery

Study Arms (1)

DePuy ASR Hip System

OTHER

A metal-on-metal bearing surface replacement system for use in resurfacing hip arthroplasty

Device: DePuy ASR Hip System

Interventions

DePuy ASR Hip System DEVICE

A metal-on-metal bearing surface replacement system for use in resurfacing hip arthroplasty

DePuy ASR Hip System

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• i) Male or female subjects, aged between 18 and 65 years inclusive.
• ii) Subjects with current indications for standard metal-on-metal (MoM) hip resurfacing arthroplasty suitable for cementless fixation in the acetabulum. These include pain, deformity, and loss of function, which are not responsive to medical treatment.
• iii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
• iv) Subjects, who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures, and are willing to return to the hospital for all the required post-operative follow-ups.

You may not qualify if:

• i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study.
• ii) Subjects with proven significant osteoporosis and poor bone quality.
• iii) Subjects with compromised renal function.
• iv) Subjects with proven metal sensitivity.
• v) Subjects with infectious, highly communicable diseases, which may limit follow-up i.e. active tuberculosis, hepatitis, immuno-compromised conditions, etc.
• vi) Women who are pregnant.
• vii) Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
• viii) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
• ix) Subjects who are currently, or have been in the last 12 months, participating in a clinical study which involves exposure to ionising radiation.
• x) Subjects who are currently involved in any injury litigation claims.

Sponsors & Collaborators

• DePuy International: lead

Study Sites (3)

Sportsmed SA

Stepney, Australia

Location

Bundesknappshaft Klinik

Püttlingen, Germany

Location

Epsom General Hospital

Surrey, United Kingdom

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid; Osteoarthritis; Collagen Diseases; Osteonecrosis; Hip Dislocation, Congenital; Slipped Capital Femoral Epiphyses

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases; Bone Diseases; Necrosis; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Developmental Dysplasia of the Hip; Musculoskeletal Abnormalities; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Osteochondrodysplasias; Bone Diseases, Developmental; Epiphyses, Slipped

Study Design

• Study Type: interventional
• Phase: phase 4
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 13, 2005
• First Posted: September 21, 2005
• Study Start: July 1, 2003
• Primary Completion: December 1, 2010
• Study Completion: December 1, 2010
• Last Updated: June 26, 2017

Record last verified: 2017-06

Locations

AU (1); GB (1); DE (1)